Democrats' decisive victories in the 2026 midterm elections for the U.S. House and Senate are poised to reshape federal health policy, setting up a legislative push to reverse cuts to the Affordable Care Act and Medicaid. According to The Associated Press, Democrats were projected to win at least 237 of 435 House seats and at least 54 Senate seats as of Wednesday afternoon, with key races in Alaska and Mississippi remaining unresolved. These results position the party to argue that voters, who prioritized healthcare affordability in pre-election surveys, have granted them a mandate to overturn changes made by President Trump and Republicans.
What the Left Is Saying
Incoming Democratic leaders and progressive allies view the election results as a direct rejection of recent federal healthcare cuts. Rep. Hakeem Jeffries of New York, widely expected to become Speaker of the House, stated on CNN that the party should restore enhanced subsidies that reduced costs for millions of Obamacare plan holders, which expired last year. Leslie Dach, chair of the advocacy group Protect Our Care, argued that Democrats must act within days of assuming control to renew these subsidies and extend the 2027 enrollment period, noting that premiums for benchmark plans are set to rise by an average of 13%.
Senator-elect Abdul El-Sayed of Michigan and other progressives are emboldened by the wins to pursue ambitious proposals, including expanding Medicare coverage to all Americans. Larry Levitt, an executive vice president at KFF, noted that Democrats will likely put forward an expansive agenda to reverse cuts to Medicaid and the ACA. Democratic leaders also plan to use their new committee chairmanships to launch oversight investigations into Health and Human Services Secretary Robert F. Kennedy Jr., focusing on his dismantling of vaccine recommendations and cuts to public health funding. Jeffries has promised to "hold the crooks accountable" by investigating clandestine drug-pricing deals and other administration actions.
What the Right Is Saying
President Trump signaled a willingness to engage with the new Democratic majority, stating in a Politico interview that he had spoken with Democratic leaders and acknowledged a message to work together "to make sure things go well for our country." "I don't want to just be sitting there for two years vetoing everything," Trump said. "They want to see things happen, too." However, Republicans have touted the Medicaid overhauls and other changes enacted through the One Big Beautiful Bill Act as signature achievements. Allison Orris, a partner at Manatt, advised clients that undoing these changes will be costly and difficult, noting that the White House must sign any legislation and that the 2025 law remains a central accomplishment for the GOP.
Conservative analysts remain skeptical about significant legislative reversals. Doug Holtz-Eakin, president of the American Action Forum, stated that lame-duck sessions are "always a disappointment" and suggested that major changes would face steep hurdles. Republicans point to the complexity of the healthcare industry and the fiscal implications of expanding Medicare or restoring subsidies as formidable challenges. While some Republicans, such as Sen. Bill Cassidy of Louisiana, have expressed concerns about specific administration appointments like Heidi Overton for FDA Commissioner, the broader GOP stance remains focused on defending the structural changes made to public health programs during the current term.
What the Numbers Show
According to KFF researchers, premiums for Affordable Care Act benchmark plans are projected to increase by an average of 13% for 2027. The enhanced subsidies that previously lowered costs for millions of enrollees expired after the Republican-controlled Congress declined to extend them. Democrats hold a projected majority of at least 54 seats in the Senate and 237 in the House, though several races remain uncalled. Polling from Impact Research, a Democratic-aligned firm, indicates that healthcare and prescription drug prices are the top cost concern for voters older than 50. Matt Hogan, a partner at Impact Research, noted that this is the third consecutive election cycle focused on affordability. Bipartisan issues with potential traction include preventing scheduled cuts to Medicare payments to doctors and fixing the No Surprises Act, though analysts deem movement on these items a long shot in the current lame-duck session.
The Bottom Line
The next few months will determine whether the new Democratic majority can translate electoral victories into legislative action on healthcare costs. Key dates include the January swearing-in of the new Congress and the January 15 deadline for the 2027 enrollment period in most states. Democrats face a strategic dilemma: they can pursue aggressive oversight and investigations into the Trump administration's health policies, or they can seek legislative compromises to restore subsidies and delay Medicaid cuts. President Trump retains veto power and may use executive actions to shape policy regardless of congressional control. The ultimate outcome will depend on whether the President and Democratic leaders can find common ground on affordability measures or if the new Congress becomes defined by partisan investigations and legislative stalemate.